Authors


Sarah L. Zakowski, BA

Latest:

Impact of 2 Employer-Sponsored Population Health Management Programs on Medical Care Cost and Utilization

Integrated health management programs combining disease prevention and disease management services, although popular with employers, may not save money, at least in their first year.




Malini Chandra, MS

Latest:

Fracture Risk Tool Validation in an Integrated Healthcare Delivery System

The FORE Fracture Risk Calculator provided rapid assessment of population hip fracture risk with some underestimation compared with observed hip fracture probabilities.


Caroline Huber, MPH

Latest:

Modeling the Impacts of Restrictive Formularies on Patients With HIV

Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.




John Barron, PharmD

Latest:

Does CAC Testing Alter Downstream Treatment Patterns for Cardiovascular Disease?

This article provides an assessment of the downstream impact of coronary artery calcium scanning on the subsequent treatment patterns of non—high-risk patients.


Nathaniel P. Katz, MD

Latest:

Analytic Models to Identify Patients at Risk for Prescription Opioid Abuse

This study evaluates the feasibility of using claims data to evaluate risk factors for prescription opioid abuse among patients in a privately insured population.


Sara Bleich, PhD

Latest:

Attributes Common to Programs That Successfully Treat High-Need, High-Cost Individuals

Many programs attempting to effectively treat high-need, high-cost individuals have not been able to lower spending, improve outcomes, or increase satisfaction. This paper suggests 8 attributes that many successful programs share.





Nancy Baum, PhD

Latest:

Tracking Spending Among Commercially Insured Beneficiaries Using a Distributed Data Model

The authors demonstrate the utility of distributed data models for reporting of local trends and variation in utilization, pricing, and spending for commercially insured beneficiaries.





Amy Wei, PharmD

Latest:

Clinical Consequences of Disseminating the Rosiglitazone FDA Safety Warning

Notifying patients and providers about the rosiglitazone cardiovascular safety alert led to sweeping changes in drug therapy that were initiated by both physicians and patients.


Elyse N. Reamer, BS

Latest:

Primary Care Appointment Availability and Nonphysician Providers One Year After Medicaid Expansion

After Medicaid expansion in Michigan, appointment availability for new Medicaid patients stably increased-this is perhaps attributable to increasing proportions of appointments scheduled with nonphysician providers.


Ya-chen Tina Shih, PhD

Latest:

Infused Chemotherapy Use in the Elderly After Patent Expiration

As calls for improving the quality and cost efficiency of oncology increase, future empirical work is needed to examine the responsiveness of oncologists' treatment decision making to incentives among patients of all ages and insurance types.


Lisa Marie Yarnell, PhD

Latest:

Diabetes and Employment Productivity: Does Diabetes Management Matter?

Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.


Tanya Temkin, MPH

Latest:

Optimizing the Use of Telephone Nursing Advice for Upper Respiratory Infection Symptoms

Telephone nursing advice for home care offers an effective and clinically appropriate way to manage upper respiratory infection symptoms for adult members of a large integrated health plan.



Simon S. K. Tang, MPH

Latest:

Effect of Patient Comorbidities on Filling of Antihypertensive Prescriptions

Patients in a Medicaid managed care plan who had cardiovascular comorbidities were not more likely to fill antihypertensive prescriptions than patients without these conditions.


Alex J. Brown, MEng, MBA

Latest:

The Value of Decreasing Health Cost Volatility

Even if they leave average cost the same, interventions that decrease cost variability have economic value.





Stephen Stemkowski, PhD, MHA

Latest:

Claims Identification of Patients With Severe Cancer-Related Symptoms

The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo